Yaz Coordinated Proceeding in California Adds Pulmonary Embolism Case
The California coordinated Yaz proceeding has added another case to its list of plaintiffs. This time the lawsuit comes from a woman who suffered from a pulmonary embolism which she and her attorneys believe was caused by the controversial birth control pills.
This coordinated proceeding is growing rapidly as more and more plaintiffs are filing Yaz lawsuits against Bayer, the makers of the controversial drospirenone-based pills. This time the plaintiff is Gina Simpson, whose case was added on January 18, 2012. Her complaint is alleging that Yaz caused her to develop a pulmonary embolism in July 2007. Simpson’s Yaz pulmonary embolism lawsuit is joining other similar cases that were filed in California and consolidated into a Judicial Council Coordinated Proceeding (JCCP). This proceeding will be presided over by Judge Elihu Berle.
Yaz lawsuits have been filed by the thousands after many patients started suffering from severe side effects, including heart attacks, strokes and blood clots that can lead pulmonary embolisms and deep vein thrombosis. The blood clots have been getting a great deal of attention from the FDA. This blood clot link caused the FDA to conduct a panel advisory meeting to investigate any links between Yaz and blood clots; however, the panel voted that the benefits outweighed the risks in taking Yaz. This ruling caused an uproar all its own after it was discovered that at least four of the panel members had financial ties to Bayer.
Gallbladder disease is another Yaz side effect that has been the subject of many new lawsuits as of late. While Yaz blood clot suits get the majority of public attention, gallbladder lawsuits are picking up steam again as more and more women are filing lawsuits among claims that Yaz or Yasmin caused them to have their gallbladders removed. With so many side effects linked to Yaz and other drospirenone-based pills, Bayer will certainly have its hands full. The recent settlement agreement the company reached with 70 plaintiffs is at least a step forward in holding Bayer accountable for not properly warning patients of the dangers linked to Yaz. Hopefully, more settlements will be reached to the satisfaction of all Yaz plaintiffs.
